AVITA Medical, Inc. (Nasdaq:RCEL)
Health Care/Life Sciences • Pharmaceuticals
CIK 1762303
Company
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Address
28159 Avenue Stanford
Suite 220
Valencia, California 91355
28159 Avenue Stanford
Suite 220
Valencia, California 91355
Employees
207
207
Stock Info
Close
$17.11
$17.11
Day Range
16.97 - 17.58
16.97 - 17.58
52 Week Range
9.16 - 21.70
9.16 - 21.70
Average volume
151.1K
151.1K
Short Interest
501.87K (02/15/24)
501.87K (02/15/24)
% of Float Shorted
4.62%
4.62%
Market Cap
$450.89M
$450.89M
Revenue
$50.14M
$50.14M
Net Income
-$35.38M
-$35.38M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, CEO & Executive Director James M Corbett |
Non-Executive Chairman Louis James Panaccio |
Independent Non-Executive Director Cary Guy Vance MBA |
Independent Non-Executive Director Robert E McNamara MBA |
Independent Non-Executive Director Suzanne Crowe MD |
Independent Non-Executive Director Jan Stern Reed |
SEC filings
Date | Form | Event |
---|---|---|
5 Dec, 2024 | 4 | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
20 Aug, 2024 | 4 | |
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | S-8 | |
8 Aug, 2024 | 10-Q | |
31 Jul, 2024 | 8-K | |
3 Jul, 2024 | 3 | |
1 Jul, 2024 | 8-K | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 8-K | |
6 Jun, 2024 | 4 | |
6 Jun, 2024 | 4 | |
3 Jun, 2024 | 4 | |
3 Jun, 2024 | 4 | |
30 May, 2024 | 8-K | |
13 May, 2024 | 10-Q | |
13 May, 2024 | 8-K | |
23 Apr, 2024 | ARS | |
23 Apr, 2024 | DEF 14A | |
11 Apr, 2024 | 8-K | |
4 Apr, 2024 | PRE 14A | |
28 Feb, 2024 | 4 | |
22 Feb, 2024 | 8-K | |
22 Feb, 2024 | 10-K | |
13 Feb, 2024 | SC 13G | |
26 Jan, 2024 | SC 13G | |
10 Jan, 2024 | 8-K | |
5 Jan, 2024 | 4 | |
5 Jan, 2024 | 4 | |
27 Dec, 2023 | 4 | |
22 Dec, 2023 | 4/A | |
14 Dec, 2023 | 4 | |
12 Dec, 2023 | 4 | |
4 Dec, 2023 | 4 | |
21 Nov, 2023 | 4 | |
16 Nov, 2023 | 4 | |
15 Nov, 2023 | 4 | |
9 Nov, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
23 Oct, 2023 | 8-K | |
18 Oct, 2023 | 8-K | |
18 Oct, 2023 | 424B5 | |
2 Oct, 2023 | 8-K | |
8 Sep, 2023 | 4 | |
16 Aug, 2023 | 4 | |
15 Aug, 2023 | 4 | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
30 Jun, 2023 | S-8 | |
26 Jun, 2023 | 8-K | |
21 Jun, 2023 | 4 | |
16 Jun, 2023 | 8-K | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 3 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 144 | |
8 Jun, 2023 | 4 | |
7 Jun, 2023 | 8-K | |
30 May, 2023 | ARS | |
16 May, 2023 | 8-K/A | |
12 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
25 Apr, 2023 | 424B2 | |
25 Apr, 2023 | EFFECT | |
21 Apr, 2023 | 8-K | |
21 Apr, 2023 | CORRESP | |
18 Apr, 2023 | UPLOAD | |
14 Apr, 2023 | DEF 14A | |
14 Apr, 2023 | S-3 | |
4 Apr, 2023 | 3 | |
4 Apr, 2023 | 3 | |
3 Apr, 2023 | PRE 14A | |
27 Mar, 2023 | 8-K | |
22 Mar, 2023 | 8-K | |
21 Mar, 2023 | 8-K | |
8 Mar, 2023 | 8-K | |
2 Mar, 2023 | 8-K | |
23 Feb, 2023 | 10-K | |
10 Feb, 2023 | 8-K | |
9 Feb, 2023 | SC 13G/A | |
24 Jan, 2023 | 3 | |
20 Jan, 2023 | 8-K | |
20 Dec, 2022 | 8-K | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 8-K | |
14 Dec, 2022 | 4 | |
22 Nov, 2022 | 4 | |
14 Nov, 2022 | 8-K | |
10 Nov, 2022 | 10-Q | |
9 Nov, 2022 | 8-K | |
19 Oct, 2022 | DEF 14A | |
7 Oct, 2022 | PRE 14A | |
30 Sep, 2022 | 8-K | CEO Change |
22 Sep, 2022 | 8-K | |
13 Sep, 2022 | 8-K | |
6 Sep, 2022 | 4 | |
2 Sep, 2022 | 8-K | |
30 Aug, 2022 | 8-K | |
12 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
22 Jul, 2022 | 8-K | |
8 Jul, 2022 | SC 13G | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4/A | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
2 Jun, 2022 | 4 | |
17 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
10 May, 2022 | 8-K | |
29 Apr, 2022 | 8-K | |
21 Apr, 2022 | 8-K | |
5 Apr, 2022 | 8-K | |
24 Mar, 2022 | 8-K | |
9 Mar, 2022 | 8-K | |
4 Mar, 2022 | 8-K | |
1 Mar, 2022 | 8-K | |
28 Feb, 2022 | 10-KT | |
25 Feb, 2022 | 4 | |
24 Feb, 2022 | 8-K | |
18 Feb, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G | |
3 Feb, 2022 | 8-K | |
11 Jan, 2022 | 8-K | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 3 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
23 Dec, 2021 | 8-K | |
15 Dec, 2021 | DEFA14A | |
15 Dec, 2021 | 8-K | |
15 Dec, 2021 | 8-K | |
9 Dec, 2021 | 8-K | |
6 Dec, 2021 | 8-K | |
12 Nov, 2021 | 8-K | |
9 Nov, 2021 | DEF 14A | |
8 Nov, 2021 | 10-Q | |
29 Oct, 2021 | PRE 14A | |
21 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
7 Sep, 2021 | 4 | |
27 Aug, 2021 | 8-K | |
26 Aug, 2021 | 10-K | |
17 Aug, 2021 | 8-K | |
2 Jul, 2021 | 3 | |
30 Jun, 2021 | 8-K | |
17 Jun, 2021 | SC 13G | |
17 Jun, 2021 | 8-K | |
4 Jun, 2021 | 8-K | |
4 Jun, 2021 | 4 | |
24 May, 2021 | 8-K | |
13 May, 2021 | 10-Q | |
11 May, 2021 | 4 | |
13 Apr, 2021 | 8-K | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 4 | |
24 Mar, 2021 | 8-K | |
19 Mar, 2021 | 4 | |
19 Mar, 2021 | UPLOAD | |
11 Mar, 2021 | 10-K/A | |
8 Mar, 2021 | 4 | |
4 Mar, 2021 | 8-K | |
1 Mar, 2021 | 8-K | |
26 Feb, 2021 | 424B5 | |
24 Feb, 2021 | 424B5 | |
19 Feb, 2021 | CORRESP | |
16 Feb, 2021 | SC 13G | |
16 Feb, 2021 | 10-Q | |
10 Feb, 2021 | UPLOAD | |
12 Jan, 2021 | 8-K |
Last update:2024-03-06 12:44:17.131039
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.